-+ 0.00%
-+ 0.00%
-+ 0.00%
S&P Lifts EssilorLuxottica Rating to A+ on Medtech Shift, Strong Cash Flow
Share
Listen to the news
06:52 AM EDT, 10/23/2026 (MT Newswires) -- S&P Global Ratings raised its long-term issuer credit rating on EssilorLuxottica (EL.PA) to A+ from A, with a stable outlook. The rating agency on Friday cited the ophthalmic lenses, frames, and sunglasses manufacturer's shift from a consumer-products business to a medtech player, with its prescription-based products acting as a "defensive buffer" against macroeconomic volatility, as well as its strong free operating cash flow. S&P forecasts EssilorLuxottica's revenue to increase 4.7% in 2026 and 7.5% annually in 2027 and 2028.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending